- Large target markets with real human impact (475,000 surgeries per year).
- $1.5 Billion addressable market (adult and pediatric pumps), and additional estimated healthcare cost reductions of $6B annually.
- Strong consumables-based business model.
- 5 issued patents, more IP in development.
- FDA 510(k) expected 18 months after Series A funding.